China Resources Boya Bio pharmaceutical Group Co Ltd (300294) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.005x

Based on the latest financial reports, China Resources Boya Bio pharmaceutical Group Co Ltd (300294) has a cash flow conversion efficiency ratio of 0.005x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥36.82 Million ≈ $5.39 Million USD) by net assets (CN¥7.46 Billion ≈ $1.09 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 300294 defensive interval ratio to measure how many days the company can operate on defensive assets alone.

China Resources Boya Bio pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how China Resources Boya Bio pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

China Resources Boya Bio pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of China Resources Boya Bio pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
TRUSTPILOT GROUP LS -01 F:6VZ	N/A
British American Tobacco PLC LSE:BATS	0.071x
Bangkok Airways Public Company Limited BK:BA	0.076x
HHC Changzhou Corp. SHE:301061	N/A
Stepan Company NYSE:SCL	0.056x
Chicony Power Technology Co Ltd TW:6412	0.072x
Ramkrishna Forgings Limited NSE:RKFORGE	-0.002x
BrightView Holdings NYSE:BV	0.026x

Annual Cash Flow Conversion Efficiency for China Resources Boya Bio pharmaceutical Group Co Ltd (2009–2025)

The table below shows the annual cash flow conversion efficiency of China Resources Boya Bio pharmaceutical Group Co Ltd from 2009 to 2025. For the full company profile with market capitalisation and key ratios, see China Resources Boya Bio pharmaceutical market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥7.46 Billion ≈ $1.09 Billion	CN¥116.69 Million ≈ $17.07 Million	0.016x	-60.96%
2024-12-31	CN¥7.49 Billion ≈ $1.10 Billion	CN¥299.78 Million ≈ $43.87 Million	0.040x	-54.33%
2023-12-31	CN¥7.32 Billion ≈ $1.07 Billion	CN¥641.73 Million ≈ $93.90 Million	0.088x	+7.06%
2022-12-31	CN¥7.28 Billion ≈ $1.07 Billion	CN¥596.44 Million ≈ $87.28 Million	0.082x	-57.88%
2021-12-31	CN¥6.92 Billion ≈ $1.01 Billion	CN¥1.35 Billion ≈ $196.87 Million	0.194x	+13.42%
2020-12-31	CN¥4.19 Billion ≈ $613.49 Million	CN¥718.58 Million ≈ $105.15 Million	0.171x	+697.00%
2019-12-31	CN¥3.99 Billion ≈ $583.66 Million	CN¥-114.51 Million ≈ $-16.76 Million	-0.029x	-410.15%
2018-12-31	CN¥3.77 Billion ≈ $551.75 Million	CN¥34.90 Million ≈ $5.11 Million	0.009x	+196.56%
2017-12-31	CN¥2.48 Billion ≈ $363.53 Million	CN¥-23.82 Million ≈ $-3.49 Million	-0.010x	-110.28%
2016-12-31	CN¥2.13 Billion ≈ $312.01 Million	CN¥198.76 Million ≈ $29.08 Million	0.093x	+20.98%
2015-12-31	CN¥1.91 Billion ≈ $279.22 Million	CN¥147.02 Million ≈ $21.51 Million	0.077x	-41.59%
2014-12-31	CN¥923.93 Million ≈ $135.20 Million	CN¥121.88 Million ≈ $17.84 Million	0.132x	+25.34%
2013-12-31	CN¥846.62 Million ≈ $123.89 Million	CN¥89.11 Million ≈ $13.04 Million	0.105x	-14.35%
2012-12-31	CN¥751.60 Million ≈ $109.98 Million	CN¥92.36 Million ≈ $13.52 Million	0.123x	-60.41%
2011-12-31	CN¥262.67 Million ≈ $38.44 Million	CN¥81.53 Million ≈ $11.93 Million	0.310x	+147.44%
2010-12-31	CN¥197.44 Million ≈ $28.89 Million	CN¥24.77 Million ≈ $3.62 Million	0.125x	-60.23%
2009-12-31	CN¥164.49 Million ≈ $24.07 Million	CN¥51.88 Million ≈ $7.59 Million	0.315x	--

About China Resources Boya Bio pharmaceutical Group Co Ltd

SHE:300294 China Biotechnology

Market Cap

$1.16 Billion

CN¥7.91 Billion CNY

Market Cap Rank

#8440 Global

#2074 in China

Share Price

CN¥15.68

Change (1 day)

-1.32%

52-Week Range

CN¥15.32 - CN¥27.54

All Time High

CN¥55.20